NPCE / NeuroPace, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

NeuroPace, Inc.
US ˙ NasdaqGM ˙ US6412881053

Deler fremragende 34,093,745 shares
Insideraktier18.954.630 shares
Insider ejerskab55,60 %
Total Insiders18
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
2323 out of 10916

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
2254 out of 10752

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

NeuroPace, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Accelmed Partners II L.P. 10% Owner - [10%] 4.432.948 4.432.948
Lisa Andrade 11.836
Joel Becker CHIEF EXECUTIVE OFFICER, Director - [D] [O] 140.436 140.436
Michael Favet Chief Executive Officer, Director - [D] [O] 407.080 407.080
Frank M Fischer Director - [D] 595.177 595.177
Greg Shaw Garfield Director - [D] 5.614.384 5.614.384
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Uri Geiger Director - [D] 14.858 14.858
Kck Ltd. 10% Owner - [10%] 0 0
Rebecca Kuhn CHIEF FINANCIAL OFFICER - [O] 131.613 131.613
Rakhi Kumar Director - [D] 19.160 19.160
Joseph Lacob Director - [D] 14.754 14.754
Martha Morrell CHIEF MEDICAL OFFICER - [O] 52.385 52.385
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Evan Norton Director - [D] 4.042.657 4.042.657
Orbimed Advisors Llc 10% Owner - [10%] 3.238.199 3.238.199
OrbiMed Capital GP VI LLC 10% Owner - [10%] 4.012.281 3.238.199
Irina Ridley Chief Legal Officer/Secretary - [O] 141.139 141.139
Renee Ryan Director - [D] 41.170 41.170
Williams Patrick F. Chief Financial Officer - [O] 68.670 68.670

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i NPCE / NeuroPace, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-11-22 Accelmed Partners II L.P. 62.398 1,4990 62.398 1,4990 93.535 311 9.7300 513.599 549,10
2022-11-21 Accelmed Partners II L.P. 327.893 1,4990 327.893 1,4990 491.512
2021-04-21 ORBIMED ADVISORS LLC 235.000 17,0000 235.000 17,0000 3.995.000
2021-04-21 Accelmed Partners II L.P. 588.235 17,0000 588.235 17,0000 9.999.995
2021-04-21 Garfield Greg Shaw 13.235 17,0000 13.235 17,0000 224.995
2021-04-21 Ridley Irina 2.352 17,0000 2.352 17,0000 39.984
2021-04-21 Fischer Frank M 50.000 17,0000 50.000 17,0000 850.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NPCE / NeuroPace, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i NPCE / NeuroPace, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-05-14 ORBIMED ADVISORS LLC 34.000 15,9400 34.000 15,9400 541.960 97 8.2500 -261.460 -48,24
2025-05-14 ORBIMED ADVISORS LLC 134.136 15,8300 134.136 15,8300 2.123.373
2025-02-20 KCK LTD. 5.270.845 9,4000 5.270.845 9,4000 49.545.943
2024-10-25 KCK LTD. 223.991 5,4513 223.991 5,4513 1.221.042
2024-10-23 KCK LTD. 147 6,0200 147 6,0200 885
2024-10-22 KCK LTD. 4.082 6,0885 4.082 6,0885 24.853
2024-10-21 KCK LTD. 3.720 6,0964 3.720 6,0964 22.679
2024-10-18 KCK LTD. 4.878 6,2919 4.878 6,2919 30.692
2024-10-17 KCK LTD. 3.294 6,2800 3.294 6,2800 20.686

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NPCE / NeuroPace, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-06-04 2026-06-03 4 Becker Joel NPCE Common Stock F - Taxes D 15,8800 -1.255 -20 140.436
2026-05-28 2026-05-27 4 Morrell Martha NPCE Common Stock F - Taxes D 17,0600 -358 -6 52.385
2026-05-28 2026-05-27 4 Becker Joel NPCE Common Stock F - Taxes D 17,0600 -1.126 -19 141.691
2026-05-19 2026-05-15 4 Becker Joel NPCE Common Stock A - Award D 45.880 142.817
2026-05-19 2026-05-15 4 Morrell Martha NPCE Common Stock A - Award D 5.460 52.743
2026-05-19 2026-05-15 4 Williams Patrick F. NPCE Common Stock A - Award D 16.820 68.670
2026-03-25 2026-03-24 4 Morrell Martha NPCE Common Stock F - Taxes D 13,2700 -1.341 -18 47.283
2026-03-24 2026-03-20 4 LACOB JOSEPH NPCE Common Stock A - Award D 13,0000 865 11 14.754
2026-03-24 2026-03-20 4 Geiger Uri NPCE Common Stock A - Award D 13,0000 913 12 14.858
2026-03-23 2026-03-20 4 Kumar Rakhi NPCE Common Stock A - Award D 13,0000 1.153 15 19.160
2026-03-23 2026-03-20 4 Fischer Frank M NPCE Common Stock A - Award D 13,0000 1.826 24 595.177
2026-03-04 2026-03-03 4 Morrell Martha NPCE Common Stock F - Taxes D 13,8300 -1.340 -19 48.624
2026-03-04 2025-12-15 4 Morrell Martha NPCE Common Stock S - Sale D 15,9700 -25.000 -399 49.964
2026-03-04 2026-03-03 4 Becker Joel NPCE Common Stock F - Taxes D 13,8300 -5.023 -69 96.937
2026-03-02 2026-02-27 4 Becker Joel NPCE Common Stock F - Taxes D 14,5800 -1.126 -16 101.960
2026-03-02 2026-02-27 4 Morrell Martha NPCE Common Stock F - Taxes D 14,5800 -358 -5 74.964
2026-02-23 2026-02-20 4 Morrell Martha NPCE Common Stock F - Taxes D 14,3400 -3.412 -49 75.322
2025-12-23 2025-12-19 4 LACOB JOSEPH NPCE Common Stock A - Award D 16,5900 678 11 13.889
2025-12-23 2025-12-19 4 Fischer Frank M NPCE Common Stock A - Award D 16,5900 1.431 24 593.351
2025-12-23 2025-12-19 4 Geiger Uri NPCE Common Stock A - Award D 16,5900 715 12 13.945
2025-12-23 2025-12-19 4 Kumar Rakhi NPCE Common Stock A - Award D 16,5900 904 15 18.007
2025-12-04 2025-12-03 4 Morrell Martha NPCE Common Stock F - Taxes D 16,6600 -1.338 -22 78.734
2025-12-01 2025-11-27 4 Becker Joel NPCE Common Stock F - Taxes D 16,5000 -1.126 -19 103.086
2025-12-01 2025-11-27 4 Morrell Martha NPCE Common Stock F - Taxes D 16,5000 -357 -6 80.072
2025-11-24 2025-11-20 4 Morrell Martha NPCE Common Stock F - Taxes D 13,5000 -3.051 -41 80.429
2025-09-22 2025-09-19 4 Kumar Rakhi NPCE Common Stock A - Award D 9,9400 1.509 15 17.103
2025-09-22 2025-09-19 4 Fischer Frank M NPCE Common Stock A - Award D 9,9400 2.389 24 591.920
2025-09-22 2025-09-19 4 Geiger Uri NPCE Common Stock A - Award D 9,9400 1.194 12 13.230
2025-09-22 2025-09-19 4 LACOB JOSEPH NPCE Common Stock A - Award D 9,9400 1.131 11 13.211
2025-09-04 2025-09-03 4 Morrell Martha NPCE Common Stock F - Taxes D 9,3600 -1.337 -13 83.480
2025-08-28 2025-08-27 4 Morrell Martha NPCE Common Stock F - Taxes D 8,8800 -357 -3 84.817
2025-08-28 2025-08-27 4 Becker Joel NPCE Common Stock F - Taxes D 8,8800 -1.126 -10 104.212
2025-08-22 2025-08-20 4 Morrell Martha NPCE Common Stock F - Taxes D 8,6600 -3.052 -26 85.174
2025-06-24 2025-06-20 4 Williams Patrick F. NPCE Common Stock A - Award D 51.850 51.850
2025-06-24 2025-06-21 4 LACOB JOSEPH NPCE Common Stock A - Award D 10,4100 1.080 11 12.080
2025-06-24 2025-03-21 4 LACOB JOSEPH NPCE Common Stock A - Award D 12,0200 935 11 11.000
2025-06-24 2024-12-21 4 LACOB JOSEPH NPCE Common Stock A - Award D 11,5300 975 11 10.065
2025-06-24 2024-09-30 4 LACOB JOSEPH NPCE Common Stock A - Award D 6,9700 1.614 11 9.090
2025-06-24 2024-06-28 4 LACOB JOSEPH NPCE Common Stock A - Award D 7,5600 1.488 11 7.476
2025-06-24 2024-03-29 4 LACOB JOSEPH NPCE Common Stock A - Award D 13,2000 852 11 5.988
2025-06-24 2023-12-29 4 LACOB JOSEPH NPCE Common Stock A - Award D 10,3100 1.091 11 5.136
2025-06-24 2023-09-29 4 LACOB JOSEPH NPCE Common Stock A - Award D 9,7300 1.156 11 4.045
2025-06-24 2023-06-30 4 LACOB JOSEPH NPCE Common Stock A - Award D 4,4900 2.505 11 2.889
2025-06-24 2025-06-21 4 Kumar Rakhi NPCE Common Stock A - Award D 10,4100 1.440 15 15.594
2025-06-24 2025-03-21 4 Kumar Rakhi NPCE Common Stock A - Award D 12,0200 1.247 15 14.154
2025-06-24 2024-12-21 4 Kumar Rakhi NPCE Common Stock A - Award D 11,5300 1.300 15 12.907
2025-06-24 2024-09-30 4 Kumar Rakhi NPCE Common Stock A - Award D 6,9700 2.152 15 11.607
2025-06-24 2024-06-28 4 Kumar Rakhi NPCE Common Stock A - Award D 7,5600 1.984 15 9.455
2025-06-24 2024-03-29 4 Kumar Rakhi NPCE Common Stock A - Award D 13,2000 1.136 15 7.471
2025-06-24 2023-12-29 4 Kumar Rakhi NPCE Common Stock A - Award D 10,3100 1.454 15 6.335
2025-06-24 2023-09-29 4 Kumar Rakhi NPCE Common Stock A - Award D 9,7300 1.541 15 4.881
2025-06-24 2023-06-30 4 Kumar Rakhi NPCE Common Stock A - Award D 4,4900 3.340 15 3.340
2025-06-24 2025-06-21 4 Geiger Uri NPCE Common Stock A - Award D 10,4100 1.140 12 12.036
2025-06-24 2025-03-21 4 Geiger Uri NPCE Common Stock A - Award D 12,0200 987 12 10.896
2025-06-24 2024-12-21 4 Geiger Uri NPCE Common Stock A - Award D 11,5300 1.029 12 9.909
2025-06-24 2024-09-30 4 Geiger Uri NPCE Common Stock A - Award D 6,9700 1.703 12 8.880
2025-06-24 2024-06-28 4 Geiger Uri NPCE Common Stock A - Award D 7,5600 1.570 12 7.177
2025-06-24 2024-03-29 4 Geiger Uri NPCE Common Stock A - Award D 13,2000 899 12 5.607
2025-06-24 2023-12-29 4 Geiger Uri NPCE Common Stock A - Award D 10,3100 1.151 12 4.708
2025-06-24 2023-09-29 4 Geiger Uri NPCE Common Stock A - Award D 9,7300 1.220 12 3.557
2025-06-24 2023-06-30 4 Geiger Uri NPCE Common Stock A - Award D 4,4900 2.337 10 2.337
2025-06-24 2025-06-21 4 Fischer Frank M NPCE Common Stock A - Award D 10,4100 2.281 24 589.531
2025-06-24 2025-03-21 4 Fischer Frank M NPCE Common Stock A - Award D 12,0200 1.975 24 587.250
2025-06-24 2024-12-21 4 Fischer Frank M NPCE Common Stock A - Award D 11,5300 2.059 24 585.275
2025-06-24 2024-09-30 4 Fischer Frank M NPCE Common Stock A - Award D 6,9700 3.407 24 583.216
2025-06-24 2024-06-28 4 Fischer Frank M NPCE Common Stock A - Award D 7,5600 3.141 24 579.809
2025-06-24 2024-03-29 4 Fischer Frank M NPCE Common Stock A - Award D 13,2000 1.799 24 576.668
2025-06-24 2023-12-29 4 Fischer Frank M NPCE Common Stock A - Award D 10,3100 2.303 24 574.869
2025-06-24 2023-09-29 4 Fischer Frank M NPCE Common Stock A - Award D 9,7300 2.440 24 572.566
2025-06-24 2023-06-30 4 Fischer Frank M NPCE Common Stock A - Award D 4,4900 4.469 20 570.126
2025-06-06 2025-06-03 4 Morrell Martha NPCE Common Stock F - Taxes D 13,5400 -1.338 -18 85.943
2025-06-06 2025-06-03 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 13,5400 -1.337 -18 131.613
2025-05-29 2025-05-27 4 Morrell Martha NPCE Common Stock F - Taxes D 12,6600 -357 -5 87.281
2025-05-29 2025-05-27 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 12,6600 -357 -5 132.950
2025-05-29 2025-05-27 4 Becker Joel NPCE Common Stock F - Taxes D 12,6600 -1.126 -14 105.338
2025-05-21 2025-05-20 4 Morrell Martha NPCE Common Stock F - Taxes D 17,9900 -3.051 -55 87.638
2025-05-21 2025-05-20 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 17,9900 -3.051 -55 133.307
2025-05-16 2025-05-14 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 15,9400 -34.000 -542 3.238.199
2025-05-16 2025-05-14 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 15,8300 -134.136 -2.123 3.272.199
2025-04-23 2025-04-22 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 10,9400 -237 -3 136.358
2025-04-23 2025-04-22 4 Morrell Martha NPCE Common Stock F - Taxes D 10,9400 -237 -3 90.689
2025-03-24 2025-03-24 4 Morrell Martha NPCE Common Stock A - Award D 11.700 90.926
2025-03-20 2025-03-10 4 Kuhn Rebecca NPCE Common Stock A - Award D 11.700 136.595
2025-03-20 2025-03-10 4 Becker Joel NPCE Common Stock A - Award D 58.500 106.464
2025-03-20 2025-02-27 4 Becker Joel NPCE Common Stock F - Taxes D 12,5600 -4.506 -57 47.964
2025-03-05 2025-03-03 4 Morrell Martha NPCE Common Stock F - Taxes D 11,8100 -1.337 -16 79.226
2025-03-05 2025-03-03 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 11,8100 -1.337 -16 124.895
2025-03-03 2025-02-27 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 12,5600 -1.430 -18 126.232
2025-03-03 2025-02-27 4 Morrell Martha NPCE Common Stock F - Taxes D 12,5600 -1.430 -18 80.563
2025-02-25 2025-02-21 4 Morrell Martha NPCE Common Stock S - Sale D 13,7213 -78.334 -1.075 81.993
2025-02-25 2024-02-12 4 Morrell Martha NPCE Common Stock M - Exercise D 0,0260 50.000 1 160.327
2025-02-25 2025-02-20 4 Morrell Martha NPCE Common Stock F - Taxes D 14,2300 -3.405 -48 43.670
2025-02-25 2025-01-22 4 Morrell Martha NPCE Common Stock F - Taxes D 14,0400 -265 -4 47.075
2025-02-25 2024-12-03 4 Morrell Martha NPCE Common Stock F - Taxes D 11,9300 -1.413 -17 47.340
2025-02-25 2024-11-20 4 Morrell Martha NPCE Common Stock F - Taxes D 9,1900 -3.045 -28 48.753
2025-02-25 2024-10-22 4 Morrell Martha NPCE Common Stock F - Taxes D 6,0000 -237 -1 51.798
2025-02-25 2024-09-03 4 Morrell Martha NPCE Common Stock F - Taxes D 7,3900 -1.334 -10 52.035
2025-02-25 2024-08-20 4 Morrell Martha NPCE Common Stock F - Taxes D 7,2400 -3.045 -22 53.369
2025-02-25 2024-07-22 4 Morrell Martha NPCE Common Stock F - Taxes D 7,6500 -237 -2 56.414
2025-02-25 2024-06-03 4 Morrell Martha NPCE Common Stock F - Taxes D 6,4600 -1.335 -9 56.511
2025-02-25 2024-05-20 4 Morrell Martha NPCE Common Stock F - Taxes D 7,9800 -3.045 -24 57.986
2025-02-25 2024-04-22 4 Morrell Martha NPCE Common Stock F - Taxes D 14,0000 -237 -3 61.268
2025-02-25 2024-03-03 4 Morrell Martha NPCE Common Stock F - Taxes D 15,9900 -1.334 -21 61.031
2025-02-25 2024-02-20 4 Morrell Martha NPCE Common Stock F - Taxes D 17,5000 -12.474 -218 62.602
2025-02-25 2024-01-31 4 Morrell Martha NPCE Common Stock M - Exercise D 0,0260 40.000 1 96.480
2025-02-25 2024-01-31 4 Morrell Martha NPCE Common Stock M - Exercise D 0,0260 12.234 0 56.480
2025-02-25 2024-01-31 4 Morrell Martha NPCE Common stock M - Exercise D 0,0260 192 0 44.246
2025-02-25 2024-01-31 4 Morrell Martha NPCE Common Stock M - Exercise D 0,0260 192 0 44.246
2025-02-25 2024-01-31 4 Morrell Martha NPCE Common Stock M - Exercise D 0,0260 192 0 44.246
2025-02-25 2024-01-22 4 Morrell Martha NPCE Common Stock F - Taxes D 14,8400 -264 -4 75.076
2025-02-25 2023-12-03 4 Morrell Martha NPCE Common Stock F - Taxes D 8,9000 -1.303 -12 75.340
2025-02-25 2023-10-22 4 Morrell Martha NPCE Common Stock F - Taxes D 6,8800 -231 -2 76.643
2025-02-25 2023-09-03 4 Morrell Martha NPCE Common Stock F - Taxes D 8,9300 -1.302 -12 76.874
2025-02-25 2023-07-22 4 Morrell Martha NPCE Common Stock F - Taxes D 4,1300 -231 -1 78.176
2025-02-25 2023-06-03 4 Morrell Martha NPCE Common Stock F - Taxes D 4,1100 -1.303 -5 78.407
2025-02-25 2023-04-22 4 Morrell Martha NPCE Common Stock F - Taxes D 4,2500 -231 -1 79.710
2025-02-25 2023-03-03 4 Morrell Martha NPCE Common Stock F - Taxes D 4,1000 -5.167 -21 79.941
2025-02-25 2023-01-22 4 Morrell Martha NPCE Common Stock F - Taxes D 2,9800 -264 -1 85.108
2025-02-25 2022-10-22 4 Morrell Martha NPCE Common Stock F - Taxes D 3,0200 -233 -1 85.372
2025-02-25 2022-07-22 4 Morrell Martha NPCE Common Stock F - Taxes D 5,5500 -231 -1 85.605
2025-02-25 2022-04-22 4 Morrell Martha NPCE Common Stock F - Taxes D 8,3200 -926 -8 85.836
2025-02-25 2025-02-20 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 14,2300 -3.405 -48 127.662
2025-02-25 2025-01-22 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 14,0400 -265 -4 118.129
2025-02-25 2024-12-03 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 11,9300 -1.334 -16 118.394
2025-02-25 2024-11-20 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 9,1900 -3.045 -28 119.728
2025-02-25 2024-10-22 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 6,0000 -237 -1 122.773
2025-02-25 2024-09-03 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 7,3900 -1.334 -10 123.010
2025-02-25 2024-08-20 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 7,2400 -3.045 -22 124.344
2025-02-25 2024-07-22 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 7,6500 -237 -2 127.389
2025-02-25 2024-06-03 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 6,4600 -1.334 -9 127.626
2025-02-25 2024-05-20 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 7,9800 -3.045 -24 128.960
2025-02-25 2024-04-22 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 14,0000 -237 -3 132.005
2025-02-25 2024-03-03 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 15,9900 -1.042 -17 132.242
2025-02-25 2024-02-20 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 17,5000 -9.832 -172 133.284
2025-02-25 2024-01-22 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 14,8400 -212 -3 143.116
2025-02-25 2023-12-03 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 8,9000 -1.010 -9 143.328
2025-02-25 2023-10-22 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 6,8800 -179 -1 144.338
2025-02-25 2023-09-03 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 8,9300 -1.010 -9 144.517
2025-02-25 2023-07-22 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 4,1300 -179 -1 145.527
2025-02-25 2023-06-03 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 4,1100 -1.010 -4 145.706
2025-02-25 2023-04-22 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 4,2500 -179 -1 146.716
2025-02-25 2023-03-03 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 4,1000 -4.019 -16 146.895
2025-02-25 2023-01-22 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 2,9800 -212 -1 150.914
2025-02-25 2022-10-22 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 3,0200 -181 -1 151.126
2025-02-25 2022-07-22 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 5,5500 -179 -1 151.307
2025-02-25 2022-04-22 4 Kuhn Rebecca NPCE Common Stock F - Taxes D 8,3200 -718 -6 151.486
2025-02-20 2025-02-20 4 KCK LTD. NPCE Common Stock S - Sale D 9,4000 -5.270.845 -49.546 0
2025-01-31 2025-01-30 4 Morrell Martha NPCE Common Stock S - Sale D 15,0000 -200 -3 86.762
2025-01-31 2025-01-29 4 Morrell Martha NPCE Common Stock S - Sale D 15,0000 -100 -2 86.962
2025-01-28 2025-01-24 4 Morrell Martha NPCE Common Stock S - Sale D 15,0100 -3.200 -48 87.062
2024-10-28 2024-10-25 4 KCK LTD. NPCE Common Stock S - Sale D 5,4513 -223.991 -1.221 5.270.845
2024-10-28 2024-10-23 4 KCK LTD. NPCE Common Stock S - Sale D 6,0200 -147 -1 5.494.836
2024-10-24 2024-10-22 4 KCK LTD. NPCE Common Stock S - Sale D 6,0885 -4.082 -25 5.494.983
2024-10-22 2024-10-21 4 KCK LTD. NPCE Common Stock S - Sale D 6,0964 -3.720 -23 5.499.065
2024-10-22 2024-10-18 4 KCK LTD. NPCE Common Stock S - Sale D 6,2919 -4.878 -31 5.502.785
2024-10-18 2024-10-17 4 KCK LTD. NPCE Common Stock S - Sale D 6,2800 -3.294 -21 5.507.663
2024-10-18 2024-10-16 4 KCK LTD. NPCE Common Stock S - Sale D 6,5705 -6.900 -45 5.510.957
2024-10-18 2024-10-15 4 KCK LTD. NPCE Common Stock S - Sale D 6,4970 -4.017 -26 5.517.857
2024-10-18 2024-10-14 4 KCK LTD. NPCE Common Stock S - Sale D 6,5393 -4.031 -26 5.521.874
2024-10-18 2024-10-11 4 KCK LTD. NPCE Common Stock S - Sale D 6,3451 -2.572 -16 5.525.905
2024-10-18 2024-10-10 4 KCK LTD. NPCE Common Stock S - Sale D 6,1170 -2.504 -15 5.528.477
2024-10-18 2024-10-09 4 KCK LTD. NPCE Common Stock S - Sale D 6,1048 -3.123 -19 5.530.981
2024-10-18 2024-10-08 4 KCK LTD. NPCE Common Stock S - Sale D 6,4253 -6.000 -39 5.534.104
2024-10-18 2024-10-07 4 KCK LTD. NPCE Common Stock S - Sale D 6,6573 -4.910 -33 5.540.104
2024-10-18 2024-10-04 4 KCK LTD. NPCE Common Stock S - Sale D 6,9185 -5.757 -40 5.545.014
2024-10-18 2024-10-03 4 KCK LTD. NPCE Common Stock S - Sale D 6,9665 -3.318 -23 5.550.771
2024-10-03 2024-10-02 4 KCK LTD. NPCE Common Stock S - Sale D 6,8700 -3.843 -26 5.554.089
2024-10-03 2024-10-01 4 KCK LTD. NPCE Common Stock S - Sale D 6,7700 -4.882 -33 5.557.932
2024-10-03 2024-09-30 4 KCK LTD. NPCE Common Stock S - Sale D 6,7300 -4.749 -32 5.562.814
2024-10-03 2024-09-27 4 KCK LTD. NPCE Common Stock S - Sale D 6,6300 -5.059 -34 5.567.563
2024-10-03 2024-09-26 4 KCK LTD. NPCE Common Stock S - Sale D 6,6200 -5.821 -39 5.572.622
2024-10-03 2024-09-25 4 KCK LTD. NPCE Common Stock S - Sale D 6,6000 -5.858 -39 5.578.443
2024-10-03 2024-09-23 4 KCK LTD. NPCE Common Stock S - Sale D 7,5400 -282 -2 5.584.301
2024-10-03 2024-09-20 4 KCK LTD. NPCE Common Stock S - Sale D 7,5000 -765 -6 5.584.583
2024-10-03 2024-09-13 4 KCK LTD. NPCE Common Stock S - Sale D 7,5900 -1.993 -15 5.585.348
2024-10-03 2024-09-06 4 KCK LTD. NPCE Common Stock S - Sale D 7,5000 -11 -0 5.587.341
2024-10-03 2024-09-04 4 KCK LTD. NPCE Common Stock S - Sale D 7,5000 -14 -0 5.587.352
2024-10-03 2024-09-03 4 KCK LTD. NPCE Common Stock S - Sale D 7,6000 -2.093 -16 5.587.366
2024-10-03 2024-08-30 4 KCK LTD. NPCE Common Stock S - Sale D 7,7600 -4.314 -33 5.589.459
2024-05-03 2024-05-03 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 14,0300 -4.674 -66 3.406.335
2024-05-03 2024-05-02 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 14,0100 -8.842 -124 3.411.009
2024-05-03 2024-05-01 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 14,0200 -15.690 -220 3.419.851
2024-04-26 2024-04-24 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 14,0600 -1.781 -25 3.435.541
2024-04-23 2024-04-23 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 14,2900 -21.791 -311 3.437.322
2024-04-23 2024-04-22 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 14,0500 -24.609 -346 3.459.113
2024-04-23 2024-04-19 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 14,0200 -18.253 -256 3.483.722
2024-04-18 2024-04-18 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 14,0600 -2.623 -37 3.501.975
2024-04-18 2024-04-17 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 14,1500 -300 -4 3.504.598
2024-04-18 2024-04-16 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 14,0100 -14.069 -197 3.504.898
2024-04-15 2024-04-12 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 14,4200 -23.101 -333 3.518.967
2024-04-15 2024-04-11 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 14,4900 -461.899 -6.693 3.542.068
2024-02-28 2024-02-27 4 Morrell Martha NPCE Common Stock A - Award D 12.500 90.262
2024-02-28 2024-02-27 4 Kuhn Rebecca NPCE Common Stock A - Award D 12.500 152.204
2024-02-28 2024-02-27 4 Becker Joel NPCE Common Stock A - Award D 52.470 52.470
2024-02-06 2024-02-05 4 Morrell Martha NPCE Common Stock S - Sale D 15,1707 -3.446 -52 77.762
2024-02-06 2024-02-02 4 Morrell Martha NPCE Common Stock S - Sale D 15,0691 -14.143 -213 81.208
2024-02-01 2024-02-01 4 Morrell Martha NPCE Common Stock S - Sale D 15,0393 -663 -10 95.351
2024-02-01 2024-01-31 4 Morrell Martha NPCE Common Stock S - Sale D 15,0752 -1.923 -29 96.014
2024-02-01 2024-01-30 4 Morrell Martha NPCE Common Stock S - Sale D 15,0954 -11.262 -170 97.937
2024-01-26 2024-01-25 4 Morrell Martha NPCE Common Stock S - Sale D 15,0000 -1 -0 109.199
2024-01-26 2024-01-24 4 Morrell Martha NPCE Common Stock S - Sale D 15,0250 -827 -12 109.200
2023-12-28 2023-12-27 4 Morrell Martha NPCE Common Stock S - Sale D 10,1239 -13.300 -135 110.027
2023-12-28 2023-12-26 4 Morrell Martha NPCE Common Stock S - Sale D 10,0000 -102 -1 123.327
2023-12-22 2023-12-20 4 Morrell Martha NPCE Common Stock S - Sale D 10,1448 -2.730 -28 123.429
2023-12-07 2023-12-06 4 Morrell Martha NPCE Common Stock S - Sale D 8,1575 -11.005 -90 126.159
2023-12-01 2023-12-01 4 KCK LTD. NPCE Common Stock S - Sale D 8,7300 -3.241 -28 5.593.773
2023-12-01 2023-11-30 4 KCK LTD. NPCE Common Stock S - Sale D 8,8400 -7.282 -64 5.597.014
2023-12-01 2023-11-29 4 KCK LTD. NPCE Common Stock S - Sale D 8,7200 -5.644 -49 5.604.296
2023-11-29 2023-11-28 4 KCK LTD. NPCE Common Stock S - Sale D 8,7500 -4.681 -41 5.609.940
2023-11-29 2023-11-27 4 KCK LTD. NPCE Common Stock S - Sale D 8,9600 -6.490 -58 5.614.621
2023-10-04 2023-10-03 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 9,0200 -700 -6 4.003.967
2023-10-04 2023-10-02 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock S - Sale I 9,0800 -7.614 -69 4.004.667
2023-02-22 2023-02-20 4 Ridley Irina NPCE Common Stock A - Award D 80.000 141.139
2023-02-22 2023-02-20 4 Kuhn Rebecca NPCE Common Stock A - Award D 80.000 139.704
2023-02-22 2023-02-21 4 Favet Michael NPCE Common Stock A - Award D 225.000 407.080
2023-02-22 2023-02-20 4 Morrell Martha NPCE Common Stock A - Award D 80.000 137.164
2023-01-09 3 Geiger Uri See Footnote (1) NPCE Common Stock I 4.432.948
2022-11-23 2022-11-22 4 Accelmed Partners II L.P. NPCE Common Stock P - Purchase D 1,4990 62.398 94 4.432.948
2022-11-23 2022-11-21 4 Accelmed Partners II L.P. NPCE Common Stock P - Purchase D 1,4990 327.893 492 4.370.550
2022-11-02 2022-10-31 4 Kuhn Rebecca NPCE Common Stock M - Exercise D 0,0260 482 0 59.704
2022-11-02 2022-10-31 4 Kuhn Rebecca NPCE Common Stock M - Exercise D 0,0260 254 0 59.222
2022-11-02 2022-10-31 4 Kuhn Rebecca NPCE Common Stock M - Exercise D 0,0260 692 0 58.968
2022-10-20 2022-10-18 4 LACOB JOSEPH NPCE Common Stock M - Exercise D 0,0260 192 0 384
2022-10-11 2022-10-07 4 Morrell Martha NPCE Common Stock M - Exercise D 0,0260 384 0 57.164
2022-10-11 2022-10-07 4 Morrell Martha NPCE Common Stock M - Exercise D 0,0260 192 0 56.780
2022-06-09 2022-06-08 4 Ridley Irina NPCE Common Stock S - Sale D 5,7780 -2.500 -14 61.139
2022-03-08 2022-03-08 4 Favet Michael NPCE Stock Option (Right to Buy) A - Award D 8,10 310.160 310.160
2022-03-08 2022-03-08 4 Favet Michael NPCE Common Stock A - Award D 155.080 182.080
2022-03-07 2022-03-03 4 Kuhn Rebecca NPCE Stock Option (Right to Buy) A - Award D 8,15 93.480 93.480
2022-03-07 2022-03-03 4 Kuhn Rebecca NPCE Common Stock A - Award D 46.740 58.276
2022-03-07 2022-03-03 4 Ridley Irina NPCE Stock Option (Right to Buy) A - Award D 8,15 83.530 83.530
2022-03-07 2022-03-03 4 Ridley Irina NPCE Common Stock A - Award D 56.987 63.639
2022-03-07 2022-03-03 4 Morrell Martha NPCE Stock Option (Right to Buy) A - Award D 8,15 93.530 93.530
2022-03-07 2022-03-03 4 Morrell Martha NPCE Common Stock A - Award D 46.760 56.588
2022-03-01 2022-02-28 4 Ridley Irina NPCE Common Stock S - Sale D 7,5386 -1.470 -11 6.652
2021-11-02 2021-11-01 4 Andrade Lisa NPCE Stock Option (Right to Buy) A - Award D 15,63 11.836 11.836
2021-10-08 2021-04-21 4 Ryan Renee NPCE Stock Option (Right to Buy) A - Award D 17,00 21.698 21.698
2021-10-08 2021-04-21 4 Norton Evan NPCE Stock Option (Right to Buy) A - Award D 17,00 21.698 21.698
2021-10-08 2021-04-21 4 Kumar Rakhi NPCE Stock Option (Right to Buy) A - Award D 17,00 21.698 21.698
2021-10-08 2021-04-21 4 LACOB JOSEPH NPCE Stock Option (Right to Buy) A - Award D 17,00 21.698 21.698
2021-06-29 2021-06-04 4/A Favet Michael NPCE Stock Option (Right to Buy) A - Award D 21,67 54.000 54.000
2021-06-29 2021-06-04 4/A Favet Michael NPCE Common Stock A - Award D 27.000 27.000
2021-06-29 2021-06-04 4/A Morrell Martha NPCE Stock Option (Right to Buy) A - Award D 21,67 16.620 16.620
2021-06-29 2021-06-04 4/A Morrell Martha NPCE Common Stock A - Award D 8.310 9.828
2021-06-29 2021-06-04 4/A Kuhn Rebecca NPCE Stock Option (Right to Buy) A - Award D 21,67 16.620 16.620
2021-06-29 2021-06-04 4/A Kuhn Rebecca NPCE Common Stock A - Award D 8.310 11.536
2021-06-29 2021-06-04 4/A Ridley Irina NPCE Stock Option (Right to Buy) A - Award D 21,67 11.540 11.540
2021-06-29 2021-06-04 4/A Ridley Irina NPCE Common Stock A - Award D 5.770 8.122
2021-06-08 2021-06-04 4 Morrell Martha NPCE Stock Option (Right to Buy) A - Award D 21,67 16.363 16.363
2021-06-08 2021-06-04 4 Morrell Martha NPCE Common Stock A - Award D 8.181 9.699
2021-06-08 2021-06-04 4 Favet Michael NPCE Stock Option (Right to Buy) A - Award D 21,67 53.180 53.180
2021-06-08 2021-06-04 4 Favet Michael NPCE Common Stock A - Award D 26.590 26.590
2021-06-08 2021-06-04 4 Ridley Irina NPCE Stock Option (Right to Buy) A - Award D 21,67 11.363 11.363
2021-06-08 2021-06-04 4 Ridley Irina NPCE Common Stock A - Award D 5.681 8.033
2021-06-08 2021-06-04 4 Kuhn Rebecca NPCE Stock Option (Right to Buy) A - Award D 21,67 16.363 16.363
2021-06-08 2021-06-04 4 Kuhn Rebecca NPCE Common Stock A - Award D 8.181 11.407
2021-04-26 2021-04-26 4 ORBIMED ADVISORS LLC See Footnotes NPCE Series B' Preferred Stock C - Conversion I 0,00 -3.605.386 0
2021-04-26 2021-04-26 4 ORBIMED ADVISORS LLC See Footnotes NPCE Series A' Preferred Stock C - Conversion I 0,00 -171.895 0
2021-04-26 2021-04-26 4 ORBIMED ADVISORS LLC See Footnotes NPCE Common Stock C - Conversion I 3.777.281 4.012.281
2021-04-26 2021-04-26 4 Fischer Frank M NPCE Series B' Preferred Stock C - Conversion D 0,00 -450.880 0
2021-04-26 2021-04-26 4 Fischer Frank M NPCE Series A' Preferred Stock C - Conversion D 0,00 -21.486 0
2021-04-26 2021-04-26 4 Fischer Frank M NPCE Common Stock C - Conversion D 472.366 565.657
2021-04-26 2021-04-26 4 Accelmed Partners II L.P. NPCE Series B' Preferred Stock C - Conversion D 0,00 3.454.422 3.454.422
2021-04-26 2021-04-26 4 Accelmed Partners II L.P. NPCE Common Stock C - Conversion D 3.454.422 4.042.657
2021-04-26 2021-04-26 4 Norton Evan NPCE Series B' Preferred Stock C - Conversion I 0,00 -3.454.422 0
2021-04-26 2021-04-26 4 Norton Evan NPCE Common Stock C - Conversion I 3.454.422 4.042.657
2021-04-26 2021-04-26 4 Garfield Greg Shaw NPCE Series B' Preferred Stock C - Conversion I 0,00 -5.271.902 0
2021-04-26 2021-04-26 4 Garfield Greg Shaw NPCE Series A' Preferred Stock C - Conversion I 0,00 -323.591 0
2021-04-26 2021-04-26 4 Garfield Greg Shaw NPCE Series B' Preferred Stock C - Conversion I 0,00 -18.032 0
2021-04-26 2021-04-26 4 Garfield Greg Shaw NPCE Series A' Preferred Stock C - Conversion I 0,00 -859 0
2021-04-26 2021-04-26 4 Garfield Greg Shaw NPCE Common Stock C - Conversion I 5.595.493 5.614.384
2021-04-26 2021-04-26 4 Garfield Greg Shaw NPCE Common Stock C - Conversion I 18.891 18.891
2021-04-26 2021-04-26 4 LACOB JOSEPH NPCE Series B' Preferred Stock C - Conversion I 0,00 -205.497 0
2021-04-26 2021-04-26 4 LACOB JOSEPH NPCE Series B; Preferred Stock C - Conversion I 0,00 -102.747 0
2021-04-26 2021-04-26 4 LACOB JOSEPH NPCE Series A' Preferred Stock C - Conversion I 0,00 -17.189 0
2021-04-26 2021-04-26 4 LACOB JOSEPH NPCE Series A' Preferred Stock C - Conversion I 0,00 -8.594 0
2021-04-26 2021-04-26 4 LACOB JOSEPH NPCE Common Stock A - Award I 334.027 351.920
2021-04-26 2021-04-26 4 Favet Michael NPCE Series B' Preferred Stock C - Conversion I 0,00 -7.219 0
2021-04-26 2021-04-26 4 Favet Michael NPCE Series A' Preferred Stock C - Conversion I 0,00 -343 0
2021-04-26 2021-04-26 4 Favet Michael NPCE Common Stock A - Award I 0,0300 15.385 0 22.947
2021-04-26 2021-04-26 4 Favet Michael NPCE Common Stock C - Conversion I 7.562 7.562
2021-04-26 2021-04-26 4 KCK LTD. NPCE Series B' Prime Preferred Stock C - Conversion D 0,00 -5.271.902 0
2021-04-26 2021-04-26 4 KCK LTD. NPCE Series A' Prime Preferred Stock C - Conversion D 0,00 -323.591 0
2021-04-26 2021-04-26 4 KCK LTD. NPCE Common Stock C - Conversion D 5.595.493 5.621.111
2021-04-23 2021-04-21 4 ORBIMED ADVISORS LLC NPCE Common Stock P - Purchase I 17,0000 235.000 3.995 235.000
2021-04-23 2021-04-21 4 Ridley Irina NPCE Common Stock P - Purchase D 17,0000 2.352 40 2.352
2021-04-23 2021-04-21 4 Accelmed Partners II L.P. NPCE Common Stock P - Purchase D 17,0000 588.235 10.000 588.235
2021-04-23 2021-04-21 4 Fischer Frank M NPCE Stock Option (Right to Buy) A - Award D 17,00 21.698 21.698
2021-04-23 2021-04-21 4 Fischer Frank M NPCE Common Stock P - Purchase D 17,0000 50.000 850 93.291
2021-04-23 2021-04-21 4 Garfield Greg Shaw NPCE Stock Option (Right to Buy) A - Award D 17,00 21.698 21.698
2021-04-23 2021-04-21 4 Garfield Greg Shaw NPCE Common Stock P - Purchase D 17,0000 13.235 225 38.853
2021-04-23 2021-04-21 4 Norton Evan NPCE Common Stock P - Purchase I 17,0000 588.235 10.000 588.235
2021-04-20 3 Morrell Martha NPCE Common Stock D 1.518
2021-04-20 3 KCK LTD. NPCE Common Stock D 25.618
2021-04-20 3 Fischer Frank M NPCE Common Stock D 43.291
2021-04-20 3 LACOB JOSEPH NPCE Common Stock I 16.833
2021-04-20 3 LACOB JOSEPH NPCE Common Stock I 868
2021-04-20 3 LACOB JOSEPH NPCE Common Stock D 192
2021-04-20 3 Kuhn Rebecca NPCE Common Stock D 3.226
2021-04-20 3 Ryan Renee NPCE Common Stock D 41.170
2021-04-20 3 Favet Michael NPCE Common Stock I 15.385
2021-04-20 3 Garfield Greg Shaw NPCE Common Stock I 25.618
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista